Delparantag

Delparantag

SCHEMBL19445836

COc1ccc(NC(=O)[C@H](CCCCN)NC(=O)c2cc(NC(=O)C(CCCCN)NC(=O)c3cc(NC(=O)[C@H](CCCCN)NC(=O)c4cc(NC(=O)[C@@H](N)CCCCN)ccc4OC)ccc3OC)ccc2OC)cc1C(N)=O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ERAP2 Q6P179 8/20 0.47
▸ LNPEP Q9UIQ6 7/20 0.47
▸ ERAP1 Q9NZ08 4/20 0.46
▸ SUV39H2 Q9H5I1 2/20 0.45
▸ LTA4H P09960 1/20 0.42
▸ AAK1 Q2M2I8 2/20 0.41
▸ KLKB1 P03952 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ TERT O14746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Delparantag SCHEMBL19445838 1.00 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
Delparantag SCHEMBL10261851 1.00 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
Delparantag SCHEMBL10260914 1.00 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
Delparantag SCHEMBL10267622 1.00 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL15138936 1.00 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
Delparantag SCHEMBL31024631 1.00 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
Delparantag SCHEMBL10262676 1.00 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL19945112 0.99 ERAP2 (0.46) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL21371608 0.99 ERAP2 (0.46) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL10261754 0.99 ERAP2 (0.46) ERAP2LNPEPERAP1SUV39H2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2709619-B1 COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS CELLCEUTIX CORP (US) 2017-10-11 — — EP disclosed
Send feedback